Genmab | GEN - PE Price to Earnings

Stock Price
1,851.50
Daily Change
19.00 1.04%
Monthly
-12.25%
Yearly
13.10%
Q1 Forecast
1,757.86

Genmab reported DKK12.75 in PE Price to Earnings for its fiscal quarter ending in September of 2025.





Pe Change Date
Agios Pharmaceuticals USD 3.56 0.68 Sep/2025
Almirall EUR 79.43 0.3 Dec/2025
Amarin USD 91.05 88.3 Jun/2023
Amgen USD 25.31 15.82 Dec/2025
argenx SE USD 31.36 2.23 Sep/2025
AstraZeneca USD 27.29 5.8 Dec/2025
Bayer EUR 5.93 0.68 Sep/2025
BioMarin Pharmaceutical USD 19.24 0.21 Dec/2025
Demant DKK 27.46 7.1 Dec/2025
Exelixis USD 602.31 586.25 Dec/2025
Fresenius Medical Care EUR 8.71 1.86 Dec/2025
Galapagos EUR 53.92 0 Mar/2025
Genmab DKK 12.75 0.62 Sep/2025
GlaxoSmithKline GBP 11.15 0.29 Dec/2025
GN Store Nord DKK 16.87 3.58 Sep/2025
GRIFOLS EUR 16.81 28.19 Sep/2025
Hikma Pharmaceutical USD 14.14 5.42 Jun/2025
Lonza CHF 67.52 12.2 Jun/2024
Merck EUR 13.37 0.13 Sep/2025
Novartis USD 15.74 0.15 Sep/2025
Regeneron Pharmaceuticals USD 18.11 2.91 Dec/2025
Roche Holding CHF 16.09 3.51 Dec/2025
Sanofi EUR 11.99 1.58 Dec/2025
UCB EUR 35.22 3.9 Jun/2025